Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Oncolytics Biotech Inc (ONCY)

Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Cancer Rates Surge: Key Biotech Stocks Leading the Charge in Oncology Drug Development BayStreet.ca - Thu Jun 27, 1:38PM CDT

USA News Group News Commentary – According to the American Cancer Society, 2024 will be the first year the USA expects to have more than 2 million new cancer cases. In order to respond to the rising...

ONCY : 0.9900 (-0.52%)
ONC.TO : 1.37 (+1.48%)
GSK : 38.21 (-0.44%)
GH : 28.87 (+2.16%)
EXEL : 22.15 (-0.45%)
GILD : 68.40 (-0.35%)
Oncolytics Biotech® Announces Productive FDA Type C Meeting on its Metastatic Breast Cancer Program Newswire.ca - Thu Jun 27, 6:00AM CDT

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapeutics for oncology, today announced...

ONCY : 0.9900 (-0.52%)
ONC.TO : 1.37 (+1.48%)
Oncolytics Biotech® Announces President and Chief Executive Officer Dr. Matt Coffey to Take Medical Leave of Absence Newswire.ca - Mon Jun 24, 6:00AM CDT

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapeutics for oncology, today announced...

ONCY : 0.9900 (-0.52%)
ONC.TO : 1.37 (+1.48%)
Biotech Advances Propel Oncology Market to $564.5B Amid Youth Cancer Spike Newswire.ca - Thu Jun 20, 4:26PM CDT

/CNW/ -- USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number of cancer...

ONCY : 0.9900 (-0.52%)
ONC.TO : 1.37 (+1.48%)
MBIO : 0.5590 (+15.40%)
LEGN : 44.74 (-2.78%)
JNJ : 146.03 (-0.28%)
NRIX : 18.93 (-9.47%)
Oncology Market Rising Towards $564.5B Amid Cancer Spike and Biotech Innovations BayStreet.ca - Thu Jun 20, 2:18PM CDT

VANCOUVER – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number of cancer cases in younger age groups than before....

ONCY : 0.9900 (-0.52%)
ONC.TO : 1.37 (+1.48%)
MBIO : 0.5590 (+15.40%)
LEGN : 44.74 (-2.78%)
JNJ : 146.03 (-0.28%)
NRIX : 18.93 (-9.47%)
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth FinancialNewsMedia - Thu Jun 20, 9:00AM CDT

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GOVX),(NYSE:GSK),(NASDAQ:AZN),(NYSE:MRK) EQNX::TICKER_END

ONCY : 0.9900 (-0.52%)
ONC.TO : 1.37 (+1.48%)
GOVX : 3.31 (+0.91%)
GSK : 38.21 (-0.44%)
AZN : 76.99 (-1.22%)
MRK : 127.72 (-0.14%)
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth GlobeNewswire - Thu Jun 20, 9:00AM CDT

ONCY : 0.9900 (-0.52%)
ONC.TO : 1.37 (+1.48%)
GOVX : 3.31 (+0.91%)
GSK : 38.21 (-0.44%)
AZN : 76.99 (-1.22%)
MRK : 127.72 (-0.14%)
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033 FinancialNewsMedia - Thu Jun 20, 7:45AM CDT

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:KYMR),(NASDAQ:GILD),(OTCQX:RHHBY),(NASDAQ:AMGN) EQNX::TICKER_END

ONCY : 0.9900 (-0.52%)
ONC.TO : 1.37 (+1.48%)
KYMR : 30.22 (-2.36%)
RHHBY : 34.4300 (-0.61%)
GILD : 68.40 (-0.35%)
AMGN : 310.77 (-0.08%)
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033 GlobeNewswire - Thu Jun 20, 7:45AM CDT

ONCY : 0.9900 (-0.52%)
ONC.TO : 1.37 (+1.48%)
KYMR : 30.22 (-2.36%)
RHHBY : 34.4300 (-0.61%)
GILD : 68.40 (-0.35%)
AMGN : 310.77 (-0.08%)
Oncolytics Biotech® Doses First Patient in Study of Pelareorep/FOLFIRINOX Combination Therapy in Pancreatic Cancer FinancialNewsMedia - Thu Jun 20, 7:15AM CDT

Demonstrating pelareorep’s synergy with modified FOLFIRINOX +/- atezolizumab in pancreatic cancer could expand the number of patients it may benefit  Funding for the study comes from the US$5 million...

ONCY : 0.9900 (-0.52%)
ONC.TO : 1.37 (+1.48%)

Barchart Exclusives

Is This Copper Mining Stock a Buy for Its Fat Dividend? Barchart - Tue Jul 2, 6:30PM CDT
Southern Copper has a higher dividend yield compared to other copper mining companies. However, its valuations are also on the higher side, making a closer examination of the risk-reward necessary for prospective investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot